Literature DB >> 27401335

Regression in cutaneous melanoma: a comprehensive review from diagnosis to prognosis.

S Ribero1,2, E Moscarella3, G Ferrara4, S Piana5, G Argenziano6, C Longo3.   

Abstract

Histological regression in primary cutaneous melanoma occurs in 10-35% of cases. Although a large body of literature exists to suggest that histological regression serves very little purpose in predicting biologic behaviour with melanoma, recognizing the presence of regression at clinical and histological ground may still retain some value in grading melanoma aggressiveness. In the current review, a comprehensive overview of the main aspects of regression will be provided. Histologically, many classifications have been reported so far, but all of them only agreed on the presence of an infiltrate of lymphocytes admixed with pigment-laden macrophages underlying an atrophic epidermis with flattened rete ridges. Upon dermoscopy, regression is also named Blue White Scar-like areas and could be variably admixed with granularity or peppering. Almost fully regressed lesions represent a main diagnostic issue in dermoscopy, and thus, confocal microscopy can be of help to identify whether the tumour is melanocytic or not. The clinical utility of regression as a prognostic factor has been challenged recently. Nowadays, evidences showed that it is less likely associated to SLN metastases.
© 2016 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2016        PMID: 27401335     DOI: 10.1111/jdv.13815

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  21 in total

1.  Accuracy of Dermoscopic Criteria for the Diagnosis of Melanoma In Situ.

Authors:  Aimilios Lallas; Caterina Longo; Marco Manfredini; Elisa Benati; Graziella Babino; Chiara Chinazzo; Zoe Apalla; Chryssoula Papageorgiou; Elvira Moscarella; Athanassios Kyrgidis; Giuseppe Argenziano
Journal:  JAMA Dermatol       Date:  2018-04-01       Impact factor: 10.282

2.  Metastatic thyroid carcinoma without identifiable primary tumor within the thyroid gland: a retrospective study of a rare phenomenon.

Authors:  Bin Xu; Theresa Scognamiglio; Perry R Cohen; Manju L Prasad; Adnan Hasanovic; Robert Michael Tuttle; Nora Katabi; Ronald A Ghossein
Journal:  Hum Pathol       Date:  2017-05-25       Impact factor: 3.466

3.  Clinical, Dermoscopic and Microscopic Features of a "Collision Tumour" Ultimately Confirmed as a Regressing Melanoma - Lessons Learnt from a Chance Diagnosis.

Authors:  Ioana Mihaela Dogaru; Mariana Costache; Lawrence Chukwudi Nwabudike; Ana Maria Oproiu; Alin Laurentiu Tatu
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-07-13

4.  Pathology of spontaneous and immunotherapy-induced tumor regression in a murine model of melanoma.

Authors:  Kim R M Blenman; Jake Wang; Shawn Cowper; Marcus Bosenberg
Journal:  Pigment Cell Melanoma Res       Date:  2019-02-27       Impact factor: 4.693

5.  Poliosis Circumscripta: A Mark of Melanoma.

Authors:  Megan D Schollenberger; Julie E Stein; Janis M Taube; Evan J Lipson
Journal:  Am J Med       Date:  2019-06-23       Impact factor: 5.928

6.  Sutton Naevi as Melanoma Simulators: Can Confocal Microscopy Help in the Diagnosis?

Authors:  Albert Brugués; Simone Ribero; Vanessa Martins da Silva; Paula Aguilera; Adriana P Garcia; Llucia Alós; Josep Malvehy; Susana Puig; Cristina Carrera
Journal:  Acta Derm Venereol       Date:  2020-05-11       Impact factor: 3.875

7.  Complete spontaneous regression of a metastatic acral melanoma with associated leukoderma.

Authors:  Isobel R Spring; Johann de Wet; Henry Francois Jordaan; Bianca Tod; Willem I Visser
Journal:  JAAD Case Rep       Date:  2017-11-06

8.  Favourable prognostic role of histological regression in stage III positive sentinel lymph node melanoma patients.

Authors:  D Zugna; R Senetta; S Osella-Abate; M T Fierro; A Pisacane; A Zaccagna; A Sapino; V Bataille; A Maurichi; F Picciotto; P Cassoni; P Quaglino; S Ribero
Journal:  Br J Cancer       Date:  2017-11-09       Impact factor: 7.640

9.  Antibody response against cancer-testis antigens MAGEA4 and MAGEA10 in patients with melanoma.

Authors:  Kadri Õunap; Kristiina Kurg; Liisi Võsa; Ülo Maiväli; Marina Teras; Anu Planken; Mart Ustav; Reet Kurg
Journal:  Oncol Lett       Date:  2018-05-10       Impact factor: 2.967

10.  Early melanoma invasivity correlates with gut fungal and bacterial profiles.

Authors:  F Vitali; R Colucci; M Di Paola; M Pindo; C De Filippo; S Moretti; D Cavalieri
Journal:  Br J Dermatol       Date:  2021-10-10       Impact factor: 11.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.